Literature DB >> 3518682

Long-term ocular manifestations in nephropathic cystinosis.

M I Kaiser-Kupfer, R C Caruso, D S Minkler, W A Gahl.   

Abstract

Eight nephropathic-cystinotic patients having undergone renal transplantation seven to 14 years previously were studied. Serious ocular complications were noted in four of the eight cases not previously reported. These included posterior synechiae, deposition of crystals on the anterior lens surface, and decreased visual acuity accompanied by impaired visual function, as measured by psychophysical and electrodiagnostic tests when possible.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3518682     DOI: 10.1001/archopht.1986.01050170096030

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  31 in total

1.  Clearance of corneal crystals in nephropathic cystinosis by topical cysteamine 0.5%.

Authors:  N P Jones; R J Postlethwaite; J L Noble
Journal:  Br J Ophthalmol       Date:  1991-05       Impact factor: 4.638

2.  A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis.

Authors:  E T Tsilou; D Thompson; A S Lindblad; G F Reed; B Rubin; W Gahl; J Thoene; M Del Monte; J A Schneider; D B Granet; M I Kaiser-Kupfer
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

Review 3.  Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature.

Authors:  Ekaterini Tsilou; Min Zhou; William Gahl; Pamela C Sieving; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2007 Jan-Feb       Impact factor: 6.048

4.  Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine.

Authors:  W A Gahl; J A Schneider; J D Schulman; J G Thoene; G F Reed
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

5.  Effect of Storage Conditions on Stability of Ophthalmological Compounded Cysteamine Eye Drops.

Authors:  Ahmed Reda; Ann Van Schepdael; Erwin Adams; Prasanta Paul; David Devolder; Mohamed A Elmonem; Koenraad Veys; Ingele Casteels; Lambertus van den Heuvel; Elena Levtchenko
Journal:  JIMD Rep       Date:  2017-12-07

6.  CTNS mutations in an American-based population of cystinosis patients.

Authors:  V Shotelersuk; D Larson; Y Anikster; G McDowell; R Lemons; I Bernardini; J Guo; J Thoene; W A Gahl
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

7.  Growth and pubertal development in nephropathic cystinosis.

Authors:  L Winkler; G Offner; F Krull; J Brodehl
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

8.  Renal transplantation in 22 children with nephropathic cystinosis.

Authors:  J H Ehrich; J Brodehl; D I Byrd; S Hossfeld; P F Hoyer; K P Leipert; G Offner; G Wolff
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

Review 9.  The eye as a window to inborn errors of metabolism.

Authors:  B T Poll-The; L J Maillette de Buy Wenniger-Prick; P G Barth; M Duran
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

10.  Clinical polymorphism of cystinosis encephalopathy. Results of treatment with cysteamine.

Authors:  M Broyer; M J Tête; G Guest; J P Berthélémé; F Labrousse; M Poisson
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.